Takeda acquires investigational coeliac therapy
admin 22nd October 2019 Uncategorised 0The Japanese pharma giant acquired the drug based on results from a phase IIa trial, in which the drug met its primary endpoint.
More: Takeda acquires investigational coeliac therapy
Source: News